类风湿-话题@MedSci

#类风湿#

751篇内容 | 7483人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1334190, encodeId=38a51334190f2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎, objectType=article, longId=185338, objectId=b9ff1853386c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9ff1853386c, replyNumber=0, likeNumber=97, createdTime=2019-12-29, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9ff1853386c, moduleTitle=吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9ff1853386c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334189, encodeId=a3c61334189a9, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Semin Arthritis Rheu：间质性肺病类型对类风湿性关节炎死亡率的影响, objectType=article, longId=185107, objectId=407518510e85, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=407518510e85, replyNumber=0, likeNumber=57, createdTime=2019-12-25, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=407518510e85, moduleTitle=Semin Arthritis Rheu：间质性肺病类型对类风湿性关节炎死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=407518510e85)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334188, encodeId=dc30133418879, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：类风湿性关节炎vitD缺乏与疾病活动性、残疾和影像学进展的关联, objectType=article, longId=185068, objectId=0d361850688f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d361850688f, replyNumber=0, likeNumber=57, createdTime=2019-12-24, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d361850688f, moduleTitle=J Rheumatol：类风湿性关节炎vitD缺乏与疾病活动性、残疾和影像学进展的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d361850688f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334187, encodeId=3414133418e66, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=艾伯维的JAK抑制剂Rinvoq，获得欧盟批准治疗类风湿性关节炎, objectType=article, longId=185034, objectId=d32d1850343b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d32d1850343b, replyNumber=0, likeNumber=69, createdTime=2019-12-23, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d32d1850343b, moduleTitle=艾伯维的JAK抑制剂Rinvoq，获得欧盟批准治疗类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d32d1850343b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334186, encodeId=ea2a13341869c, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Sci Rep：类风湿性关节炎与健康对照手腕热成像特征的比较, objectType=article, longId=184918, objectId=7b231849188f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b231849188f, replyNumber=0, likeNumber=65, createdTime=2019-12-20, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b231849188f, moduleTitle=Sci Rep：类风湿性关节炎与健康对照手腕热成像特征的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b231849188f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334185, encodeId=d7ea13341856e, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Arthritis Rheumatol：胰岛素抵抗通路与类风湿性关节炎的疾病活动性有关, objectType=article, longId=184876, objectId=a9d71848e60e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9d71848e60e, replyNumber=0, likeNumber=64, createdTime=2019-12-19, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9d71848e60e, moduleTitle=Arthritis Rheumatol：胰岛素抵抗通路与类风湿性关节炎的疾病活动性有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9d71848e60e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334184, encodeId=70a01334184d2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：类风湿性关节炎b/tsDMARD停药和坚持二线治疗的原因, objectType=article, longId=184790, objectId=3498184e9022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3498184e9022, replyNumber=0, likeNumber=78, createdTime=2019-12-17, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3498184e9022, moduleTitle=J Rheumatol：类风湿性关节炎b/tsDMARD停药和坚持二线治疗的原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3498184e9022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334183, encodeId=cdf8133418331, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：疼痛和自我报告关节肿胀是类风湿性关节炎患者报告发作的主要驱动因素, objectType=article, longId=184788, objectId=986b184e88a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=986b184e88a1, replyNumber=0, likeNumber=82, createdTime=2019-12-17, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=986b184e88a1, moduleTitle=J Rheumatol：疼痛和自我报告关节肿胀是类风湿性关节炎患者报告发作的主要驱动因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=986b184e88a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334182, encodeId=5baf133418290, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=NEJM：类风湿关节炎患者的伸缩式手指-病例报道, objectType=article, longId=184642, objectId=020118464243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=020118464243, replyNumber=0, likeNumber=68, createdTime=2019-12-13, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=020118464243, moduleTitle=NEJM：类风湿关节炎患者的伸缩式手指-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=020118464243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334181, encodeId=9b9813341819f, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=FDA批准了新的甲氨蝶呤注射制剂RediTrex用于治疗类风湿关节炎, objectType=article, longId=184296, objectId=9b4818429678, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b4818429678, replyNumber=0, likeNumber=84, createdTime=2019-12-08, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b4818429678, moduleTitle=FDA批准了新的甲氨蝶呤注射制剂RediTrex用于治疗类风湿关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b4818429678)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334180, encodeId=dc4f133418072, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=吉利德的JAK1抑制剂filgotinib治疗类风湿性关节炎III期临床成功, objectType=article, longId=184287, objectId=1a1218428e0d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a1218428e0d, replyNumber=0, likeNumber=53, createdTime=2019-12-08, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a1218428e0d, moduleTitle=吉利德的JAK1抑制剂filgotinib治疗类风湿性关节炎III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a1218428e0d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334179, encodeId=5d3b13341e947, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Arthritis Rheumatol：类风湿性关节炎的B细胞滑膜炎和临床表型, objectType=article, longId=184217, objectId=58b418421ed6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58b418421ed6, replyNumber=0, likeNumber=69, createdTime=2019-12-07, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58b418421ed6, moduleTitle=Arthritis Rheumatol：类风湿性关节炎的B细胞滑膜炎和临床表型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58b418421ed6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334178, encodeId=dff313341e8fc, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=类风湿性嗜中性皮炎1 例, objectType=article, longId=184001, objectId=1c0d184001d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c0d184001d3, replyNumber=0, likeNumber=140, createdTime=2019-12-04, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c0d184001d3, moduleTitle=类风湿性嗜中性皮炎1 例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c0d184001d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334177, encodeId=de8113341e708, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=欧洲委员会批准Celltrion的英夫利昔单抗皮下制剂仿制药Remsima SC，用于治疗类风湿性关节炎, objectType=article, longId=183993, objectId=3c02183993a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c02183993a4, replyNumber=0, likeNumber=44, createdTime=2019-12-04, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c02183993a4, moduleTitle=欧洲委员会批准Celltrion的英夫利昔单抗皮下制剂仿制药Remsima SC，用于治疗类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c02183993a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334176, encodeId=9a6113341e614, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：定义类风湿性关节炎抗TNF治疗的原发性和继发性无应答, objectType=article, longId=183735, objectId=4203183e353a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4203183e353a, replyNumber=0, likeNumber=64, createdTime=2019-11-30, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4203183e353a, moduleTitle=J Rheumatol：定义类风湿性关节炎抗TNF治疗的原发性和继发性无应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4203183e353a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334175, encodeId=89b813341e5db, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：类风湿性关节炎患者的矫形外科手术, objectType=article, longId=183733, objectId=f98e183e337f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f98e183e337f, replyNumber=0, likeNumber=68, createdTime=2019-11-30, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f98e183e337f, moduleTitle=J Rheumatol：类风湿性关节炎患者的矫形外科手术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f98e183e337f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334174, encodeId=b7e013341e40b, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：颈椎受累在使用目标治疗策略的类风湿性关节炎患者中很罕见, objectType=article, longId=183732, objectId=d8e8183e3288, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8e8183e3288, replyNumber=0, likeNumber=73, createdTime=2019-11-30, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8e8183e3288, moduleTitle=J Rheumatol：颈椎受累在使用目标治疗策略的类风湿性关节炎患者中很罕见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8e8183e3288)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334173, encodeId=08e813341e392, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：使用利妥昔单抗治疗全身性类风湿性血管炎, objectType=article, longId=183654, objectId=e3b318365420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3b318365420, replyNumber=0, likeNumber=80, createdTime=2019-11-28, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3b318365420, moduleTitle=J Rheumatol：使用利妥昔单抗治疗全身性类风湿性血管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3b318365420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334172, encodeId=357a13341e27f, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Lancet Rheumato：类风湿性关节炎患者如何选择流感疫苗？, objectType=article, longId=183380, objectId=892318338080, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=892318338080, replyNumber=0, likeNumber=82, createdTime=2019-11-23, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=892318338080, moduleTitle=Lancet Rheumato：类风湿性关节炎患者如何选择流感疫苗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=892318338080)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334171, encodeId=011213341e165, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：类风湿性关节炎的心血管事件风险, objectType=article, longId=183367, objectId=a98b18336e34, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a98b18336e34, replyNumber=0, likeNumber=49, createdTime=2019-11-23, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a98b18336e34, moduleTitle=J Rheumatol：类风湿性关节炎的心血管事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a98b18336e34)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

类风湿

2020-05-29

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎

2019-12-29

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Semin Arthritis Rheu：间质性肺病类型对类风湿性关节炎死亡率的影响

2019-12-25

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：类风湿性关节炎vitD缺乏与疾病活动性、残疾和影像学进展的关联

2019-12-24

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

艾伯维的JAK抑制剂Rinvoq，获得欧盟批准治疗类风湿性关节炎

2019-12-23

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Sci Rep：类风湿性关节炎与健康对照手腕热成像特征的比较

2019-12-20

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Arthritis Rheumatol：胰岛素抵抗通路与类风湿性关节炎的疾病活动性有关

2019-12-19

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：类风湿性关节炎b/tsDMARD停药和坚持二线治疗的原因

2019-12-17

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：疼痛和自我报告关节肿胀是类风湿性关节炎患者报告发作的主要驱动因素

2019-12-17

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

NEJM：类风湿关节炎患者的伸缩式手指-病例报道

2019-12-13

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

FDA批准了新的甲氨蝶呤注射制剂RediTrex用于治疗类风湿关节炎

2019-12-08

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

吉利德的JAK1抑制剂filgotinib治疗类风湿性关节炎III期临床成功

2019-12-08

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Arthritis Rheumatol：类风湿性关节炎的B细胞滑膜炎和临床表型

2019-12-07

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

类风湿性嗜中性皮炎1 例

2019-12-04

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

欧洲委员会批准Celltrion的英夫利昔单抗皮下制剂仿制药Remsima SC，用于治疗类风湿性关节炎

2019-12-04

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：定义类风湿性关节炎抗TNF治疗的原发性和继发性无应答

2019-11-30

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：类风湿性关节炎患者的矫形外科手术

2019-11-30

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：颈椎受累在使用目标治疗策略的类风湿性关节炎患者中很罕见

2019-11-30

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：使用利妥昔单抗治疗全身性类风湿性血管炎

2019-11-28

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Lancet Rheumato：类风湿性关节炎患者如何选择流感疫苗？

2019-11-23

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：类风湿性关节炎的心血管事件风险

2019-11-23

科室
- - 订阅+
  - 更多科室
工具
服务